Vitafol (cholecalciferol 1000 [iu] pyridoxine hydrochloride 2.5 mg folic acid 0.4 mg levomefolate calcium 0.6 mg cyanocobalamin 12 ug iron 18 mg iodine 150 ug) Dailymed
![Vitafol tablet, coated - (cholecalciferol 1000 [iu] pyridoxine hydrochloride 2.5 mg folic acid 0.4 mg levomefolate calcium 0.6 mg cyanocobalamin 12 ug iron 18 mg iodine 150 ug) image](https://pillboxwebp.pillsync.com/capsule.webp)
Boxed Warning
Warning
Go PRO for all pill images
Composition
Amount per Tablet:
VITAMINS AND MINERALS
Vitamin D (as cholecalciferol) 25 mcg Vitamin B6 (as pyridoxine hydrochloride) 2.5 mg Folate (as Folic acid USP 680 mcg DFE and L-methylfolate calcium 1020 mcg DFE, as Metafolin ® CAS# 151533-22-1) 1700 mcg DFE Vitamin B12 (as cyanocobalamin) 12 mcg Iron (as ferrous fumarate) 18 mg Iodine (as potassium iodide) 150 mcg Other Ingredients
Microcrystalline cellulose, hydroxypropylcellulose, modified food starch, croscarmellose sodium, magnesium stearate, sucrose, silicon dioxide, dibasic calcium phosphate, polyvinyl alcohol, titanium dioxide (as color), polyethylene glycol, talc, sodium ascorbate, medium chain triglycerides, dl-alpha-tocopherol, sucralose, FD&C Blue #2 Aluminum Lake.
Usage
Vitafol ®-Nano provides vitamin and mineral supplementation prior to conception, throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother.
Contraindications
Vitafol ®-Nano is contraindicated in patients with hypersensitivity to any of its components or color additives.
Folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid.
Iron therapy is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver.
Cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (vitamin B12).
Warning
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or a Poison Control Center immediately.
Warnings/precautions
Vitamin D supplementation should be used with caution in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones. High doses of vitamin D can lead to elevated levels of calcium that reside in the blood and soft tissues. Bone pain, high blood pressure, formation of kidney stones, renal failure, and increased risk of heart disease can occur.
Prolonged use of iron salts may produce iron storage disease.
Folate, especially in doses above 1700 mcg DFE (1000 mcg folic acid) daily, may obscure pernicious anemia, in that hematologic remission may occur while neurological manifestations remain progressive.
The use of folic acid doses above 1 mg daily may precipitate or exacerbate the neurological damage of vitamin B12 deficiency.
Avoid Overdosage. Keep out of the reach of children.
DRUG INTERACTIONS
High doses of folic acid may result in decreased serum levels of the anticonvulsant drugs; carbamazepine, fosphenytoin, phenytoin, phenobarbitol, valproic acid. Folic acid may decrease a patient's response to methotrexate.
Vitamin D supplementation should not be given with large amounts of calcium in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones.
Consult appropriate references for additional specific vitamin-drug interactions.
Information for Patients
Patients should be counseled to disclose all medical conditions, including use of all medications, vitamins and supplements, pregnancy, and breast-feeding.
Pediatric Use
Not for pediatric use.
Adverse Reactions
Adverse reactions have been reported with specific vitamins and minerals, but generally at doses substantially higher than those in Vitafol ®-Nano. However, allergic and idiosyncratic reactions are possible at any dose. Reported adverse events include skin ailments, gastrointestinal complaints, glucose abnormalities, and visual problems.
Directions For Use
Before, during and after pregnancy, one tablet daily, or as directed by a physician.
How Supplied
Vitafol ®-Nano is available as a light blue, round tablet imprinted with "94" on one side. Available in 30 cts in HDPE bottle, 0642-0094-01.
STORAGE AND HANDLING SECTION
Store at room temperature approximately 20°-25°C (68°-77°F). Avoid excessive heat, light, moisture and humidity.
Rx
Distributed by: Exeltis USA, Inc. Florham Park, NJ 07932 1-877-324-9349
www.exeltisusa.com ©2021 Exeltis USA, Inc.
Metafolin® is a trademark of Merck KGaA, Darmstadt, Germany
U.S. Patent No. 6,441,168B1; 5,997,915; 6,254,904; 6,808,725; 7,172,778 and 7,674,490
Rev. January 2021 0940101-01
Principal Display Panel - 30 Tablet Bottle Label
0642-0094-01
VITAFOL Nano
Smallest Prenatal Supplement with essential nutrients
30 Tablets
R x DIETARY SUPPLEMENT
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
